Septic Shock Global Clinical Trials Review, H2, 2012
Publisher Name » GlobalData
Published Date » 2012-08-15
No. Of Pages » 87
Septic Shock Global Clinical Trials Review, H2, 2012
GlobalData's clinical trial report, Septic Shock Global Clinical Trials Review, H2, 2012" provides data on the Septic Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Septic Shock. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Septic Shock. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Septic Shock Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Septic Shock, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Septic Shock Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Septic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Septic Shock Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Septic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Septic Shock Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Septic Shock Therapeutics Clinical Trials, G7 Countries, 2012* 17
Septic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Septic Shock Therapeutics Clinical Trials, E7 Countries, 2012* 19
Septic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Septic Shock Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Septic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Septic Shock Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Septic Shock Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25
Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 26
Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Septic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2012* 32
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 33
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Gambro KK, 2012* 34
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Kompetenznetz Sepsis, 2012* 35
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Fraser Health Corporate Office, 2012* 36
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Thrombologic ApS, 2012* 37
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Athlomics Pty Ltd, 2012* 38
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire francais de Fractionnement et de Biotechnologies, 2012* 39
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Aventis Behring GmbH, 2012* 40
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Atox Bio Inc., 2012* 41
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 42
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Corporation, 2012* 43
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2012* 44
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Research & Diagnostic Antibodies, 2012* 45
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirius Genomics Inc., 2012* 46
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 47
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2012* 48
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 49
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 50
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012* 51
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2012* 52
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical Center Leeuwarden, 2012* 53
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2012* 54
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2012* 55
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Carolinas Healthcare System, 2012* 56
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 57
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, 2012* 58
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Versailles, 2012* 59
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2012* 60
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2012* 61
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by London Health Sciences Centre, 2012* 62
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 63
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 64
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2012* 65
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 66
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2012* 67
Septic Shock Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Septic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Septic Shock Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15
Septic Shock Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Septic Shock Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Septic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Septic Shock Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Septic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Septic Shock Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Septic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 26
Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29
Septic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
GlobalData Methodology 85
Table of Contents 2
List of Tables 5
List of Figures 6
List of Tables 5
List of Figures 6
Introduction 7
Septic Shock 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Septic Shock 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Septic Shock Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Ferring Pharmaceuticals, Inc. 32
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 32
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
Gambro KK 34
Clinical Trial Overview of Gambro KK 34
Kompetenznetz Sepsis 35
Clinical Trial Overview of Kompetenznetz Sepsis 35
Fraser Health Corporate Office 36
Clinical Trial Overview of Fraser Health Corporate Office 36
Thrombologic ApS 37
Clinical Trial Overview of Thrombologic ApS 37
Athlomics Pty Ltd 38
Clinical Trial Overview of Athlomics Pty Ltd 38
Laboratoire francais de Fractionnement et de Biotechnologies 39
Clinical Trial Overview of Laboratoire francais de Fractionnement et de Biotechnologies 39
Aventis Behring GmbH 40
Clinical Trial Overview of Aventis Behring GmbH 40
Atox Bio Inc. 41
Clinical Trial Overview of Atox Bio Inc. 41
Eisai Inc. 42
Clinical Trial Overview of Eisai Inc. 42
Green Cross Corporation 43
Clinical Trial Overview of Green Cross Corporation 43
Children's Healthcare of Atlanta Inc. 44
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 44
Research & Diagnostic Antibodies 45
Clinical Trial Overview of Research & Diagnostic Antibodies 45
Sirius Genomics Inc. 46
Clinical Trial Overview of Sirius Genomics Inc. 46
Eli Lilly and Company 47
Clinical Trial Overview of Eli Lilly and Company 47
Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
Sapienza University of Rome 48
Clinical Trial Overview of Sapienza University of Rome 48
Beth Israel Deaconess Medical Center 49
Clinical Trial Overview of Beth Israel Deaconess Medical Center 49
Assistance Publique - Hopitaux de Paris 50
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 50
Charite- Universitatsmedizin Berlin 51
Clinical Trial Overview of Charite- Universitatsmedizin Berlin 51
The University of Texas Health Science Center at Houston 52
Clinical Trial Overview of The University of Texas Health Science Center at Houston 52
The Medical Center Leeuwarden 53
Clinical Trial Overview of The Medical Center Leeuwarden 53
University Hospital Inselspital, Berne 54
Clinical Trial Overview of University Hospital Inselspital, Berne 54
Herlev Hospital 55
Clinical Trial Overview of Herlev Hospital 55
Carolinas Healthcare System 56
Clinical Trial Overview of Carolinas Healthcare System 56
University of Sao Paulo 57
Clinical Trial Overview of University of Sao Paulo 57
Seattle Children's Hospital 58
Clinical Trial Overview of Seattle Children's Hospital 58
University of Versailles 59
Clinical Trial Overview of University of Versailles 59
Mahidol University 60
Clinical Trial Overview of Mahidol University 60
Montpellier University Hospital 61
Clinical Trial Overview of Montpellier University Hospital 61
London Health Sciences Centre 62
Clinical Trial Overview of London Health Sciences Centre 62
Samsung Medical Center 63
Clinical Trial Overview of Samsung Medical Center 63
University of Colorado 64
Clinical Trial Overview of University of Colorado 64
University of Copenhagen 65
Clinical Trial Overview of University of Copenhagen 65
National Taiwan University Hospital 66
Clinical Trial Overview of National Taiwan University Hospital 66
Rush University Medical Center 67
Clinical Trial Overview of Rush University Medical Center 67
Five Key Clinical Profiles 68
Septic Shock 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Septic Shock 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Septic Shock Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Ferring Pharmaceuticals, Inc. 32
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 32
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
Gambro KK 34
Clinical Trial Overview of Gambro KK 34
Kompetenznetz Sepsis 35
Clinical Trial Overview of Kompetenznetz Sepsis 35
Fraser Health Corporate Office 36
Clinical Trial Overview of Fraser Health Corporate Office 36
Thrombologic ApS 37
Clinical Trial Overview of Thrombologic ApS 37
Athlomics Pty Ltd 38
Clinical Trial Overview of Athlomics Pty Ltd 38
Laboratoire francais de Fractionnement et de Biotechnologies 39
Clinical Trial Overview of Laboratoire francais de Fractionnement et de Biotechnologies 39
Aventis Behring GmbH 40
Clinical Trial Overview of Aventis Behring GmbH 40
Atox Bio Inc. 41
Clinical Trial Overview of Atox Bio Inc. 41
Eisai Inc. 42
Clinical Trial Overview of Eisai Inc. 42
Green Cross Corporation 43
Clinical Trial Overview of Green Cross Corporation 43
Children's Healthcare of Atlanta Inc. 44
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 44
Research & Diagnostic Antibodies 45
Clinical Trial Overview of Research & Diagnostic Antibodies 45
Sirius Genomics Inc. 46
Clinical Trial Overview of Sirius Genomics Inc. 46
Eli Lilly and Company 47
Clinical Trial Overview of Eli Lilly and Company 47
Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
Sapienza University of Rome 48
Clinical Trial Overview of Sapienza University of Rome 48
Beth Israel Deaconess Medical Center 49
Clinical Trial Overview of Beth Israel Deaconess Medical Center 49
Assistance Publique - Hopitaux de Paris 50
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 50
Charite- Universitatsmedizin Berlin 51
Clinical Trial Overview of Charite- Universitatsmedizin Berlin 51
The University of Texas Health Science Center at Houston 52
Clinical Trial Overview of The University of Texas Health Science Center at Houston 52
The Medical Center Leeuwarden 53
Clinical Trial Overview of The Medical Center Leeuwarden 53
University Hospital Inselspital, Berne 54
Clinical Trial Overview of University Hospital Inselspital, Berne 54
Herlev Hospital 55
Clinical Trial Overview of Herlev Hospital 55
Carolinas Healthcare System 56
Clinical Trial Overview of Carolinas Healthcare System 56
University of Sao Paulo 57
Clinical Trial Overview of University of Sao Paulo 57
Seattle Children's Hospital 58
Clinical Trial Overview of Seattle Children's Hospital 58
University of Versailles 59
Clinical Trial Overview of University of Versailles 59
Mahidol University 60
Clinical Trial Overview of Mahidol University 60
Montpellier University Hospital 61
Clinical Trial Overview of Montpellier University Hospital 61
London Health Sciences Centre 62
Clinical Trial Overview of London Health Sciences Centre 62
Samsung Medical Center 63
Clinical Trial Overview of Samsung Medical Center 63
University of Colorado 64
Clinical Trial Overview of University of Colorado 64
University of Copenhagen 65
Clinical Trial Overview of University of Copenhagen 65
National Taiwan University Hospital 66
Clinical Trial Overview of National Taiwan University Hospital 66
Rush University Medical Center 67
Clinical Trial Overview of Rush University Medical Center 67
Five Key Clinical Profiles 68
Appendix 84
Abbreviations 84
Abbreviations 84
Definitions 84
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 87
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 87
List of Tables
Septic Shock Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Septic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Septic Shock Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Septic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15
Septic Shock Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Septic Shock Therapeutics Clinical Trials, G7 Countries, 2012* 17
Septic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Septic Shock Therapeutics Clinical Trials, E7 Countries, 2012* 19
Septic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Septic Shock Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Septic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Septic Shock Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Septic Shock Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25
Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 26
Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Septic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2012* 32
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 33
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Gambro KK, 2012* 34
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Kompetenznetz Sepsis, 2012* 35
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Fraser Health Corporate Office, 2012* 36
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Thrombologic ApS, 2012* 37
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Athlomics Pty Ltd, 2012* 38
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire francais de Fractionnement et de Biotechnologies, 2012* 39
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Aventis Behring GmbH, 2012* 40
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Atox Bio Inc., 2012* 41
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 42
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Corporation, 2012* 43
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2012* 44
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Research & Diagnostic Antibodies, 2012* 45
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirius Genomics Inc., 2012* 46
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 47
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2012* 48
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 49
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 50
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012* 51
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2012* 52
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical Center Leeuwarden, 2012* 53
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2012* 54
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2012* 55
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Carolinas Healthcare System, 2012* 56
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 57
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, 2012* 58
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Versailles, 2012* 59
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2012* 60
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2012* 61
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by London Health Sciences Centre, 2012* 62
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 63
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 64
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2012* 65
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 66
Septic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2012* 67
List of Figures
List of FiguresSeptic Shock Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Septic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Septic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Septic Shock Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Septic Shock Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Septic Shock Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15
Septic Shock Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Septic Shock Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Septic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Septic Shock Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Septic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Septic Shock Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Septic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Septic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Septic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 26
Septic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
Septic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29
Septic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31
GlobalData Methodology 85
Upcoming Reports:
|
Fiber Optics Components Market - Global Industry Size, Market Share, Trends, Analysis and Forecasts, 2011-2017
By - Transparency Market Research
The science of transmission of data, pictures and voice by the passage of light through thin transparent fibers is called fiber optics technology. It is the technique that utilizes glass or plastic threads for the transmission of data over a network. It comprises of bundled threads of fiber optics used to transmit data over a network which are modulated into light waves having a specific wavelength. It is a flexible, transparent thread made of glass, slightly thicker than the human hair. It performs the function of waveguide to transmit data that has been modulated in the light waves,...
|
|
Metallocene Technologies Market- Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Metallocene based technology is estimated to boost the growth of the polyolefin polyethylene, and polypropylene industries. The major players operating in the global polyethylene and polypropylene industries invest heavily in developing metallocene technologies to obtain a cutting edge advantage over their competitors.
The investment made for developing metallocene technologies accounts for approximately 75% of the total R&D investment made in the polyolefins industry with the remaining being spent for nourishing conventional technologies. Metallocene based...
|
|
Photonic Crystals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Photonic crystals are elements that impact the motion of photons. These crystals usually have optical nanostructures. Similar to the periodicity of semiconductor crystals that impact the flow of electrons, photonic crystals impact the flow of photons. They are found naturally and aggressive research has been carried out in order to acquire the varied benefits of the properties it possesses.
The market is segmented based on applications that comprise of displays, optical fibers, LEDs, discrete and integrated optical components, image sensors, solar and PV cells, lasers and...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- Global and China Piano Industry Report, 2012-2013
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
